Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Reducing Reliance on China for Rare Earths Production and Processing

7 Biggest Lithium-mining Companies in 2024

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Gold-mining Companies (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Trending Press Releases

Westgold Strategic Alliance and Placement

Deeper Drilling Discovers Substantially Thicker Mineralisation at Horden Lake; Corresponding DHEM Results Indicate Exciting Depth Continuity

CRML Joins Russell Indexes

Silver Crown Royalties Completes Offering of Subscription Receipts and Amalgamation With Reporting Issuer

Ramelius Makes Strategic Investment in Spartan Resources

Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study

More Press Releases
Trending Companies

Ora Gold Limited

OAU:AU

Sona Nanotech

SONA:CNX

Boss Energy Limited

BOE:AU

GTI Energy

GTR:AU
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook (Updated for Q2)

2024 Copper Outlook Report

Start Here: Investing in Tech

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Bristol-Myers Squibb

NYSE:BMY
Press Releases

Bristol Myers Squibb Reports First Quarter Financial Results for 2023

Bristol Myers Squibb Announces Leadership Transition Plan

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Interactive Chart

×